327 related articles for article (PubMed ID: 31307011)
1. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
Thakur S; Daley B; Klubo-Gwiezdzinska J
J Mol Endocrinol; 2019 Aug; 63(2):R17-R35. PubMed ID: 31307011
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
3. The Role of Lithium in Management of Endocrine Tumors-A Comprehensive Review.
Thakur S; Tobey A; Klubo-Gwiezdzinska J
Front Oncol; 2019; 9():1092. PubMed ID: 31750236
[No Abstract] [Full Text] [Related]
4. The anticancer potential of metformin on prostate cancer.
Zaidi S; Gandhi J; Joshi G; Smith NL; Khan SA
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):351-361. PubMed ID: 30651580
[TBL] [Abstract][Full Text] [Related]
5. Repurposing old drugs to chemoprevention: the case of metformin.
Heckman-Stoddard BM; Gandini S; Puntoni M; Dunn BK; DeCensi A; Szabo E
Semin Oncol; 2016 Feb; 43(1):123-133. PubMed ID: 26970131
[TBL] [Abstract][Full Text] [Related]
6. Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.
León-González AJ; Jiménez-Vacas JM; Fuentes-Fayos AC; Sarmento-Cabral A; Herrera-Martínez AD; Gahete MD; Luque RM
Curr Opin Pharmacol; 2021 Oct; 60():17-26. PubMed ID: 34311387
[TBL] [Abstract][Full Text] [Related]
7. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area.
Tulipano G
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884872
[TBL] [Abstract][Full Text] [Related]
8. Metformin effects on biochemical recurrence and metabolic signaling in the prostate.
Winters B; Plymate S; Zeliadt SB; Holt S; Zhang X; Hu E; Lin DW; Morrissey C; Wooldridge B; Gore JL; Porter MP; Wright JL
Prostate; 2015 Nov; 75(15):1694-703. PubMed ID: 26201966
[TBL] [Abstract][Full Text] [Related]
9. Metformin: its emerging role in oncology.
Micic D; Cvijovic G; Trajkovic V; Duntas LH; Polovina S
Hormones (Athens); 2011; 10(1):5-15. PubMed ID: 21349801
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
11. Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.
Sivalingam VN; Myers J; Nicholas S; Balen AH; Crosbie EJ
Hum Reprod Update; 2014; 20(6):853-68. PubMed ID: 25013215
[TBL] [Abstract][Full Text] [Related]
12. Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.
Snima KS; Pillai P; Cherian AM; Nair SV; Lakshmanan VK
Curr Cancer Drug Targets; 2014; 14(8):727-36. PubMed ID: 25329671
[TBL] [Abstract][Full Text] [Related]
13. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.
Lipner MB; Marayati R; Deng Y; Wang X; Raftery L; O'Neil BH; Yeh JJ
PLoS One; 2016; 11(1):e0147113. PubMed ID: 26760500
[TBL] [Abstract][Full Text] [Related]
14. Metformin and thyroid disease.
Meng X; Xu S; Chen G; Derwahl M; Liu C
J Endocrinol; 2017 Apr; 233(1):R43-R51. PubMed ID: 28196954
[TBL] [Abstract][Full Text] [Related]
15. Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications.
García-Sáenz M; Lobaton-Ginsberg M; Ferreira-Hermosillo A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454163
[TBL] [Abstract][Full Text] [Related]
16. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
17. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
Gong J; Kelekar G; Shen J; Shen J; Kaur S; Mita M
Target Oncol; 2016 Aug; 11(4):447-67. PubMed ID: 26864078
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer.
Guppy A; Jamal-Hanjani M; Pickering L
Future Oncol; 2011 Jun; 7(6):727-36. PubMed ID: 21675836
[TBL] [Abstract][Full Text] [Related]
19. Metformin and Breast Cancer: Molecular Targets.
Faria J; Negalha G; Azevedo A; Martel F
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
[TBL] [Abstract][Full Text] [Related]
20. Metformin in selected malignancies in women.
Markowska A; Stanislawiak-Rudowicz J; Kasprzak T; Markowska J; Szarszewska M
Ginekol Pol; 2022; 93(5):416-421. PubMed ID: 35072253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
